NCT07235111 Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases
| NCT ID | NCT07235111 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ospedale Policlinico San Martino |
| Condition | Alzheimer Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2025-02-28 |
| Primary Completion | 2034-09-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2025-02-28 with a primary completion date of 2034-09-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to use 'omics' sciences, employing the most advanced technologies currently available, in order to identify pathogenic genomic variants, proteins and/or altered molecular pathways in neurodegenerative diseases and to obtain a new and more complete characterisation of subjects affected by the neurodegenerative diseases under study. Thanks to the integration of genomic, gene expression (transcriptomic and epigenomic), protein and metabolic data and clinical data, the study also aims to identify new markers for the diagnosis, prognosis, also in terms of response to therapy, and monitoring of neurodegenerative diseases. The study involves the enrolment of at least 1.200 individuals with neurodegenerative disease.
Eligibility Criteria
Inclusion Criteria • Patients suffering from neurodegenerative diseases Exclusion Criteria • Patients not suffering from neurodegenerative diseases
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07235111 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07235111 currently recruiting?
Yes, NCT07235111 is actively recruiting participants. Contact the research team at paola.mandich@unige.it for enrollment information.
Where is the NCT07235111 trial being conducted?
This trial is being conducted at Genoa, Italy.
Who is sponsoring the NCT07235111 clinical trial?
NCT07235111 is sponsored by Ospedale Policlinico San Martino. The trial plans to enroll 1,200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.